A primary human osteogenic sarcoma was visualized in situ by external gamma-camera imaging following administration of 131I-labelled anti-osteogenic sarcoma monoclonal antibody 791T/36. A xenograft of the tumour established in immunodeprived mice also showed localization of 1311-791T/36 determined b
Quantitative evaluation of the localization of a monoclonal antibody (791T/36) in human osteogenic sarcoma xenografts
โ Scribed by Pimm, M.V.; Baldwin, R.W.
- Book ID
- 122369043
- Publisher
- Elsevier Science
- Year
- 1984
- Weight
- 979 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0277-5379
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The blood kinetics and tumour localization of a conjugate of methotrexate (MTX) and MAb 791T136 were examined i n nude mice with human tumour xenografts. The antibod moiety of the conjugate was detected by labelling with l2J and the drug moiety was assayed using a radioimmunoassay for methotrexate.
To demonstrate the precise distribution and binding of in vivo injected monoclonal antibodies on histological tumour sections, we have biotinylated our primary antibody AUA I. Biotinylated antibody was injected into nude mice bearing simultaneous subcutaneous and intraperitoneal xenografts of the hu
A monoclonal antibody (RBU/01) was raised against human thyroglobulin and its suitability for the immunohistochemical staining of thyroglobulin was determined on fixed, wax-embedded tissue, using the peroxidase anti-peroxidase (PAP) method. The antibody was then used to demonstrate the expression of
The mouse monoclonal antibody (MAb) AUAI, when applied on LoVo tumour sections, reacts by staining all tumour cells, on their cell surfaces. To investigate the accessibility of these sites t o antibody when the tumour is present as a solid mass in vivo, subcutaneous xenografts of LoVo were f i r s t